Citadel Advisors - SOLENO THERAPEUTICS INC ownership

SOLENO THERAPEUTICS INC's ticker is SLNO and the CUSIP is 834203200. A total of 20 filers reported holding SOLENO THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of SOLENO THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$75,000
+2.7%
405,412
+23.0%
0.00%
Q1 2022$73,000
-56.3%
329,523
-19.3%
0.00%
Q4 2021$167,000
-46.3%
408,276
+21.3%
0.00%
Q3 2021$311,000
-17.5%
336,451
+1.6%
0.00%
Q2 2021$377,000
+44.4%
331,178
+59.7%
0.00%
Q1 2021$261,000
+94.8%
207,389
+197.4%
0.00%
Q4 2020$134,000
+1.5%
69,735
+32.8%
0.00%
Q3 2020$132,000
-30.2%
52,508
-38.4%
0.00%
Q2 2020$189,000
+410.8%
85,300
+376.0%
0.00%
Q1 2019$37,000
+23.3%
17,920
+38.6%
0.00%
Q2 2018$30,00012,9260.00%
Other shareholders
SOLENO THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Abingworth LLP 10,302,602$9,500,0002.16%
Nantahala Capital Management 9,765,129$9,028,0000.28%
ORACLE INVESTMENT MANAGEMENT INC 2,132,000$1,971,0000.24%
Granite Point Capital Management, L.P. 701,838$649,0000.05%
OPPENHEIMER & CO INC 639,140$591,0000.01%
Ikarian Capital, LLC 121,694$112,0000.01%
Warberg Asset Management LLC 30,000$28,0000.01%
Levy Wealth Management Group, LLC 10,000$9,0000.01%
Ergoteles LLC 74,525$69,0000.00%
TWO SIGMA ADVISERS, LP 744,000$688,0000.00%
View complete list of SOLENO THERAPEUTICS INC shareholders